Concepedia

Olga Burenkova

OB

Statistics

Publications

12

Citations

1.5K

H-Index

11

Active since

2003

Affiliations

Baylor College of Medicine(Current)

Millennium Engineering and Integration (United States)

Vavilov Institute of General Genetics

Merrimack Pharmaceuticals (United States)

Massachusetts Institute of Technology

Olga Burenkova is an author at Baylor College of Medicine specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2003–2022

12

Publications

12

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Mark Manfredi, Jeffrey Ecsedy, Kristan Meetze et al. · Proceedings of the National Academy of Sciences · 2007 · 413 citations · Full text

Medicine, Oncology, Pharmacology +14

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties

Kevin Dooley, Russell E. McConnell, Ke Xu et al. · Molecular Therapy · 2021 · 309 citations · Full text

Engineering, Bioengineering, Pharmaceutics +17

An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation

Birgit Schoeberl, Anthony C. Faber, Danan Li et al. · Cancer Research · 2010 · 261 citations · Full text

Medicine, Oncology, Pharmacology +16

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

Sushrut Kamerkar, Charan Leng, Olga Burenkova et al. · Science Advances · 2022 · 247 citations · Full text

Life Sciences, Immunology, Oncology +17

Activation of voltage-sensitive sodium channels during oxygen deprivation leads to apoptotic neuronal death

Kenneth Banasiak, Olga Burenkova, Gabriel G. Haddad · Neuroscience · 2004 · 90 citations

Life Sciences, Neurobiology, Neuroscience +16

1–5 of 12